Prolonged apnea after succinylcholine in a case treated with cytostatics for cancer.
D000759:Adjuvants, Anesthesia / Q000009:adverse effects*; D000768:Anesthesia, General; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001049:Apnea / Q000139:chemically induced* / Q000201:enzymology; D001201:Ascites / Q000188:drug therapy; D002800:Cholinesterase Inhibitors; D005260:Female; D006221:Halothane; D006801:Humans; D006985:Hyperventilation; D008111:Liver Function Tests; D008558:Melphalan / Q000009:adverse effects; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009609:Nitrous Oxide; D009946:Organothiophosphorus Compounds / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010534:Peritoneal Neoplasms / Q000201:enzymology / Q000601:surgery; D010998:Pleurisy / Q000188:drug therapy; D013390:Succinylcholine / Q000009:adverse effects*
D000759:Adjuvants, Anesthesia; D000970:Antineoplastic Agents; D002800:Cholinesterase Inhibitors; D009946:Organothiophosphorus Compounds; D013390:Succinylcholine; D009609:Nitrous Oxide; D008558:Melphalan; D006221:Halothane